ZA200703907B - Compounds for flaviviridae treatment - Google Patents

Compounds for flaviviridae treatment

Info

Publication number: ZA200703907B
Authority: ZA; South Africa
Prior art keywords: compounds; flaviviridae; treatment; flaviviridae treatment
Prior art date: 2004-12-23

Application number

ZA200703907A

Other languages

English (en)

Inventor

Weidmann Beat

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-23

Filing date

2007-05-15

Publication date

2009-08-26

2007-05-15 Application filed by Novartis Ag filed Critical Novartis Ag

2009-08-26 Publication of ZA200703907B publication Critical patent/ZA200703907B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Zoology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA200703907A 2004-12-23 2007-05-15 Compounds for flaviviridae treatment ZA200703907B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US63867604P	2004-12-23	2004-12-23

Publications (1)

Publication Number	Publication Date
ZA200703907B true ZA200703907B (en)	2009-08-26

Family

ID=36218613

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200703907A ZA200703907B (en)	2004-12-23	2007-05-15	Compounds for flaviviridae treatment

Country Status (17)

Country	Link
US (1)	US20090214464A1 (xx)
EP (1)	EP1830870A1 (xx)
JP (1)	JP2008525458A (xx)
KR (1)	KR20070089954A (xx)
CN (1)	CN101084005A (xx)
AU (1)	AU2005322241B2 (xx)
BR (1)	BRPI0519355A2 (xx)
CA (1)	CA2587586A1 (xx)
IL (1)	IL183780A0 (xx)
MA (1)	MA29097B1 (xx)
MX (1)	MX2007007721A (xx)
NO (1)	NO20073765L (xx)
NZ (1)	NZ555142A (xx)
RU (1)	RU2007128098A (xx)
TN (1)	TNSN07240A1 (xx)
WO (1)	WO2006071618A1 (xx)
ZA (1)	ZA200703907B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1603512A2 (en)	2003-03-17	2005-12-14	Albany Molecular Research, Inc.	Novel cyclosporins
US7378391B2 (en)	2004-09-29	2008-05-27	Amr Technology, Inc.	Cyclosporin alkyne analogues and their pharmaceutical uses
WO2006039164A2 (en)	2004-09-29	2006-04-13	Amr Technology, Inc.	Novel cyclosporin analogues and their pharmaceutical uses
US7196161B2 (en)	2004-10-01	2007-03-27	Scynexis Inc.	3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
EP1812037A4 (en)	2004-10-06	2009-11-11	Amr Technology Inc	ALKYNES OF CYCLOSPORINE AND THEIR USEFUL AS PHARMACEUTICAL AGENTS
CN105169369B (zh)	2005-09-30	2019-10-18	中美华世通生物医药科技（武汉）有限公司	治疗和预防丙型肝炎感染的方法和药物组合物
ATE498630T1 (de)	2005-09-30	2011-03-15	Scynexis Inc	Arylalkyl- und heteroarylalkyl-derivate von cyclosporin a bei der behandlung und vorbeugung einer virusinfektion
US7696166B2 (en)	2006-03-28	2010-04-13	Albany Molecular Research, Inc.	Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en)	2006-03-28	2010-04-13	Albany Molecular Research, Inc.	Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
JP5377293B2 (ja)	2006-05-19	2013-12-25	スシネキスインク	眼疾患の治療及び予防方法
US7576057B2 (en)	2006-11-20	2009-08-18	Scynexis, Inc.	Cyclic peptides
CA2724523A1 (en)	2008-06-06	2010-01-07	Scynexis, Inc.	Novel macrocyclic peptides
CN102307892A (zh)	2008-12-31	2012-01-04	西尼克斯公司	环孢菌素a的衍生物
WO2011063076A1 (en)	2009-11-19	2011-05-26	Itherx Pharmaceuticals, Inc.	Methods of treating hepatitis c virus with oxoacetamide compounds
GB201116559D0 (en)	2011-09-26	2011-11-09	Univ Leuven Kath	Novel viral replication inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI111730B (fi) *	1990-11-02	2003-09-15	Novartis Ag	Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
US5908621A (en) *	1995-11-02	1999-06-01	Schering Corporation	Polyethylene glycol modified interferon therapy
FR2757521B1 (fr) *	1996-12-24	1999-01-29	Rhone Poulenc Rorer Sa	Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757522B1 (fr) *	1996-12-24	1999-01-29	Rhone Poulenc Rorer Sa	Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
GB9811854D0 (en) *	1998-06-02	1998-07-29	Ciba Geigy Ag	Organic compounds
US20040033946A1 (en) *	2000-10-19	2004-02-19	Futoshi Shibasaki	Cell damage inhibitor
GB0320638D0 (en) *	2003-09-03	2003-10-01	Novartis Ag	Organic compounds
EA012650B1 (ru) *	2004-10-01	2009-12-30	Дебиофарм С.А.	ПРИМЕНЕНИЕ [D-MeAla]-[EtVal]-ЦИКЛОСПОРИНА ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИИ ГЕПАТИТА С И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ [D-MeAla]-[EtVal]-ЦИКЛОСПОРИН
WO2006071619A1 (en) *	2004-12-23	2006-07-06	Novartis Ag	Compositions for hcv treatment

2005
- 2005-12-20 AU AU2005322241A patent/AU2005322241B2/en not_active Ceased
- 2005-12-20 NZ NZ555142A patent/NZ555142A/en not_active IP Right Cessation
- 2005-12-20 US US11/719,684 patent/US20090214464A1/en not_active Abandoned
- 2005-12-20 EP EP05854721A patent/EP1830870A1/en not_active Withdrawn
- 2005-12-20 BR BRPI0519355-9A patent/BRPI0519355A2/pt not_active IP Right Cessation
- 2005-12-20 MX MX2007007721A patent/MX2007007721A/es not_active Application Discontinuation
- 2005-12-20 WO PCT/US2005/046058 patent/WO2006071618A1/en not_active Ceased
- 2005-12-20 JP JP2007548376A patent/JP2008525458A/ja active Pending
- 2005-12-20 CA CA002587586A patent/CA2587586A1/en not_active Abandoned
- 2005-12-20 CN CNA2005800439925A patent/CN101084005A/zh active Pending
- 2005-12-20 RU RU2007128098/15A patent/RU2007128098A/ru not_active Application Discontinuation
- 2005-12-20 KR KR1020077014268A patent/KR20070089954A/ko not_active Withdrawn
2007
- 2007-05-15 ZA ZA200703907A patent/ZA200703907B/xx unknown
- 2007-06-07 IL IL183780A patent/IL183780A0/en unknown
- 2007-06-18 MA MA29999A patent/MA29097B1/fr unknown
- 2007-06-22 TN TNP2007000240A patent/TNSN07240A1/fr unknown
- 2007-07-19 NO NO20073765A patent/NO20073765L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TNSN07240A1 (en)	2008-11-21
WO2006071618A1 (en)	2006-07-06
RU2007128098A (ru)	2009-01-27
IL183780A0 (en)	2007-09-20
MA29097B1 (fr)	2007-12-03
NZ555142A (en)	2010-03-26
BRPI0519355A2 (pt)	2009-01-20
EP1830870A1 (en)	2007-09-12
CA2587586A1 (en)	2006-07-06
CN101084005A (zh)	2007-12-05
KR20070089954A (ko)	2007-09-04
US20090214464A1 (en)	2009-08-27
MX2007007721A (es)	2007-08-14
AU2005322241B2 (en)	2010-02-18
AU2005322241A1 (en)	2006-07-06
NO20073765L (no)	2007-09-19
JP2008525458A (ja)	2008-07-17

Publication	Publication Date	Title
IL183780A0 (en)	2007-09-20	Compounds for flaviviridae treatment
IL180200A0 (en)	2007-07-04	5-aza-7 deazapurine derivatives for treating flaviviridae
GB0423554D0 (en)	2004-11-24	Therapeutic compounds
ZA200703908B (en)	2009-06-24	Compositions for HCV treatment
GB0518390D0 (en)	2005-10-19	Therapeutic compounds
IL179145A0 (en)	2007-03-08	Therapeutic compounds
GB0518237D0 (en)	2005-10-19	Therapeutic compounds
GB0509326D0 (en)	2005-06-15	Therapeutic compounds
GB0509573D0 (en)	2005-06-15	Therapeutic compounds
GB0518361D0 (en)	2005-10-19	Therapeutic compounds
GB0522881D0 (en)	2005-12-21	Therapeutic compounds
GB0509405D0 (en)	2005-06-15	Therapeutic compounds
GB0420424D0 (en)	2004-10-20	Therapeutic compounds
GB0513747D0 (en)	2005-08-10	Therapeutic compounds
GB2430002B (en)	2009-06-03	Well treatment
GB0522130D0 (en)	2005-12-07	Therapeutic compounds
GB0526107D0 (en)	2006-02-01	Therapeutic Compounds
GB0426141D0 (en)	2004-12-29	Treatment
GB0424085D0 (en)	2004-12-01	Well treatment
GB0518235D0 (en)	2005-10-19	Therapeutic compounds
GB0427138D0 (en)	2005-01-12	Therapeutic compounds
GB0423767D0 (en)	2004-12-01	Therapeutic compounds
GB0417560D0 (en)	2004-09-08	Therapeutic compounds
HK1111613A (en)	2008-08-15	Compounds for flaviviridae treatment
GB0515580D0 (en)	2005-09-07	Therapeutic compounds